SPP1 and hepatocellular carcinoma: The experimental block of SPP1 significantly strengthened the efficiency of anti-PD1 immunotherapy, limited CAF infiltration, and exacerbated the infiltration and cytotoxic effect of CD8+ T cells in the mouse model of HCC, indicating the destruction of the TIB structures [97].